REGULATED PRESS RELEASE published on 02/25/2025 at 07:00, 1 year 3 months ago Biophytis announces its participation in the 15th International Conference on Frailty and Sarcopenia Research (ICFSR) Biophytis to participate in ICFSR 15th International Conference on Frailty and Sarcopenia Research, presenting data on BIO101 for obesity-associated sarcopenia. Event in Toulouse, March 12-14 Biophytis Sarcopenia ICFSR BIO101 Obesity
BRIEF published on 02/11/2025 at 07:05, 1 year 4 months ago Biophytis Outlines 2025 Strategic Plans Strategic Partnerships Biophytis Clinical Development Obesity Treatment Sarcopenia
REGULATED PRESS RELEASE published on 02/11/2025 at 07:00, 1 year 4 months ago Biophytis unveils its outlook strategies for 2025 Biophytis unveils its strategic outlook for 2025, focusing on clinical development and commercialization plans for BIO101 (20-Hydroxyecdysone) in obesity and sarcopenia, with key partnerships and agreements Biophytis Clinical Development BIO101 Obesity Strategic Outlook
BRIEF published on 01/27/2025 at 07:05, 1 year 4 months ago Biophytis to Participate in BIOMED FORUM Investor Conference Biophytis Investor Conference Healthcare Sector Paris BIOMED Forum
REGULATED PRESS RELEASE published on 01/27/2025 at 07:00, 1 year 4 months ago Biophytis announces its participation to the BIOMED FORUM investor conference Biophytis announces participation in Biomed Forum investor conference to engage with investors and share updates on developments for age-related diseases Biophytis Investor Conference Healthcare Sector BIOMED Forum Age-related Diseases
BRIEF published on 01/21/2025 at 07:05, 1 year 4 months ago Biophytis and AskHelpU Form Co-Development Partnership in China Biophytis China ALS Co-development AskHelpU
REGULATED PRESS RELEASE published on 01/21/2025 at 07:00, 1 year 4 months ago Biophytis and AskHelpU Sign a Co-Development Agreement in Rare Neuromuscular Diseases in China Biophy's and AskHelpU sign a co-development agreement for rare neuromuscular diseases in China. The agreement aims to evaluate BIO101's efficacy in ALS, potentially offering a major therapeutic solution for patients Biophy's ALS AskHelpU Co-development Agreement Neuromuscular Diseases
BRIEF published on 01/14/2025 at 07:05, 1 year 4 months ago Biophytis Enters Exclusive Negotiations for BIO101 in China Biophytis Age-related Diseases BIO101 Pharmaceutical Partnership China Licensing
REGULATED PRESS RELEASE published on 01/14/2025 at 07:00, 1 year 4 months ago Biophytis Enters Exclusive Negotiations with a Chinese Pharmaceutical Company to License BIO101 Biophytis enters exclusive negotiations with a Chinese pharmaceutical company to license BIO101 for viral respiratory infections, sarcopenia, and obesity. The potential partnership aims to develop and commercialize the drug in China's growing pharmaceutical market Biophytis Exclusive Negotiations Chinese Pharmaceutical Company BIO101 License Viral Respiratory Infections
BRIEF published on 01/08/2025 at 07:05, 1 year 5 months ago Biophytis Secures €8.6 Million for Obesity Program Clinical Development Debt Conversion Obesity Program Biophytis Financing New Investors
Published on 06/12/2026 at 00:00, 43 minutes ago Redwood AI Enters LOI to Explore Pathogen Tracking Through AI Genomics at the Border of Rwanda and the Democratic Republic of Congo with Aim of Potentially Tracing Ebola Virus Disease
Published on 06/12/2026 at 00:00, 43 minutes ago UraniumX Closes Oversubscribed Flow-Through Private Placement
Published on 06/11/2026 at 22:55, 1 hour 48 minutes ago Gamma Resources to Hold Annual General Meeting on August 12, 2026
Published on 06/11/2026 at 22:15, 2 hours 28 minutes ago BlackBerry to Hold Annual Meeting of Shareholders on June 25, 2026
Published on 06/11/2026 at 22:05, 2 hours 38 minutes ago First Canadian Graphite to Present at Planet MicroCap
Published on 06/11/2026 at 22:15, 2 hours 28 minutes ago HHLA Annual General Meeting resolves transfer of class A shares to majority shareholder
Published on 06/11/2026 at 20:27, 4 hours 16 minutes ago Turkiye Garanti Bankasi A.S.: Garanti BBVA 2025 TSRS-Aligned Sustainability Report
Published on 06/11/2026 at 19:50, 4 hours 53 minutes ago GSMA Intelligence Finds Operators Could Be the Real Game-Changers of the 2026 World Cup
Published on 06/11/2026 at 19:30, 5 hours 13 minutes ago EQS-Adhoc: Tirlán Co-operative Society Limited: PROPOSED SECONDARY PLACING & DIRECTED BUYBACK
Published on 06/11/2026 at 18:47, 5 hours 56 minutes ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 06/11/2026 at 17:45, 6 hours 58 minutes ago BAIKOWSKI: Annual General Meeting of June 11, 2026 - Dividend of €0.30 per share, to be paid out on June 30, 2026
Published on 06/11/2026 at 08:45, 15 hours 58 minutes ago Air Liquide and ArianeGroup renew strategic industrial partnership with two major Ariane 6 contracts
Published on 06/11/2026 at 08:30, 16 hours 13 minutes ago Aéroports de Paris S.A - €600 million new bond issue
Published on 06/10/2026 at 18:29, 1 day 6 hours ago ICADE – PR – OUTCOME OF THE COMBINED GENERAL MEETING HELD ON JUNE 10 2026